Pancreatic Cancer, Research and Clinical Trials

Meet the investigator: Daniel D. Billadeau, Ph.D.

By Nicole Ferrara • December 11, 2019
Estimated reading time: 1 minute

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Daniel D. Billadeau, Ph.D., an oncology researcher at Mayo Clinic in Rochester, Minnesota, talks about his work investigating pancreatic cancer. Dr. Billadeau is also a principal investigator of the Mayo Clinic Pancreatic Cancer SPORE.

Related

This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.

cancer pancreatic cancer Pancreatic Cancer research Research and Clinical Trials SPORE
Subscribe
Request an Appointment
Find a Clinical Trial
Top cancer research stories of 2024

Mayo Clinic Comprehensive Cancer Center researchers spent 2024 mining patient data, leveraging artificial intelligence and conducting clinical trials to reveal insights that improve patient care.

Laparoscopic Whipple procedure for pancreatic cancer

Dr. Michael Kendrick explains how the minimally invasive laparoscopic approach to the Whipple procedure can be easier on the patient.

Advances in pancreatic cancer screening

Dr. Michael Wallace, a Mayo Clinic interventional endoscopist, discusses pancreatic cancer screening and research advancements.